DataM Intelligence Projects In-Silico Clinical Trials Market to Reach $6.39 Billion by 2033
According to DataM Intelligence, the in-silico clinical trials market is expected to grow from $3.95 billion in 2024 to $6.39 billion by 2033, driven by AI-based modeling and virtual patient simulations.